Brevibloc Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2,500 mg/250 mL (10 mg/mL), 250 mL Single Use IntraVia container, packaged in 10 x 250 mL Single Use IntraVia containers per carton, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product Code 2J1415, NDC 10019-055-61.
Published July 9, 2014 · Recall initiated: June 16, 2014
Summary
FDA records drug Class II recall D-1413-2014, published July 9, 2014 and initiated June 16, 2014. Recalling firm: Baxter Healthcare Corp.; Status: Terminated; Reported quantity: 20,810 containers; Lot: Lot #: C926923, Exp 01/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: Complaints received of discolored solution identified as subvisible particles of iron oxide that are agglomerating.
What to do
Voluntary: Firm initiated · Letter
Get an email if BREVIBLOC has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- BREVIBLOC
- Manufacturer
- Baxter Healthcare Corp.
- Distributor
- Nationwide
- Lot
- Lot #: C926923, Exp 01/16
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABrevibloc DOUBLE STRENGTH Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2000mg/100mL (20May 18, 2016
- FDABystolic (nebivolol) tablets, 20 mg/tablet. 7 Tablet Professional Sample Bottle, Rx Only. ForestJuly 9, 2014
- FDAIsoniazid Tablets, USP, 300 mg, Rx only, packaged in a) 100-count bottles, NDC 0143-1261-01, b) 1000-countJuly 9, 2014
- FDAVenlafaxine Hydrochloride Extended-Release Tablets, 150 mg, Rx only, Packaged in 30 Count and 90 CountJuly 9, 2014
- FDAMAS Omni Immune PRO ControlsJuly 2, 2014
- FDAMAS Omni Immune ControlsJuly 2, 2014
Questions about this recall
Was Brevibloc Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2,500 mg/250 mL (10 mg/mL), 250 mL Single Use IntraVia container, packaged in 10 x 250 mL Single Use IntraVia containers per carton, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product Code 2J1415, NDC 10019-055-61. recalled?
Yes. FDA published recall D-1413-2014 on July 9, 2014. Reported hazard: Presence of Particulate Matter: Complaints received of discolored solution identified as subvisible particles of iron oxide that are agglomerating.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: BREVIBLOC.